Projects per year
Abstract
Vaccine formulations administered in the periphery must activate naive immune cells within the lymph node. In this study, we have directly cannulated the ovine lymphatic vessels to investigate the cellular and molecular mechanisms that transfer information from the periphery into the local draining lymph node via the afferent lymph. Inclusion of poly(I:C) into a liposomal vaccine formulation enhances the neutrophil-associated inflammatory immune response in afferent lymph and increases antigen uptake by migratory dendritic cells (DCs). Interestingly, antigen positive migratory DCs undergo discordant maturation, with peak expression of CD86 at 4h and CD80 at 48-72h post vaccination. Afferent lymph monocytes up-regulate expression of genes related to inflammatory and anti-viral immune phenotypes following vaccination however show no differentiation into APCs prior to their migration to the local lymph node as measured by surface MHC II expression. Finally, this study reveals the addition of poly(I:C) increases systemic antigen-specific humoral immunity. These findings provide a detailed understanding of the real time in vivo immune response induced by liposomes incorporating the innate immune agonist poly(I:C) utilising a vaccination setting comparable to that administered in humans.
Original language | English |
---|---|
Pages (from-to) | 6183 - 6192 |
Number of pages | 10 |
Journal | Vaccine |
Volume | 32 |
Issue number | 47 |
DOIs | |
Publication status | Published - 2014 |
Projects
- 1 Finished
-
Characterisation and development of adjuvants for new generation veterinary and human vaccines
Meeusen, E.
Australian Research Council (ARC), Pfizer (Australia) (trading as Pfizer Australia Pty Limited)
1/07/08 → 30/06/11
Project: Research